Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073047
Status:
COMPLETED
Last Update Posted:
2009-07-20
First Post:
2003-11-14
Brief Title:
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Sponsor:
Facet Biotech
Organization:
Facet Biotech
Organization Data
Organization:
Facet Biotech
Class:
INDUSTRY
Study ID:
1008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Facet Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Nancy Teasdale Director Regulatory Affairs
Old Organization:
None